| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 05/30/2007 | CN1318402C Pyrrolidine-2-carboxylic acid hydrozide derivatives for use as metalloprotease inhibitors |
| 05/30/2007 | CN1318093C Injections for eye tissue containing drug bound to polyethylene glycol |
| 05/30/2007 | CN1318091C Use of biologically active HIV-1 Tat, fragments or derivatives thereof for preventing or therapeutic vaccination and/or treating other diseases |
| 05/30/2007 | CN1318086C Use of soluble CTLA4 molecule in preparation of medicine composition for treating rheumatic diseases |
| 05/30/2007 | CN1318031C Compositions containing benzoxazinone and nucleoside like materials |
| 05/29/2007 | US7223835 Cyclic peptide mimetic for treating cancer; anticarcinogenic agents |
| 05/29/2007 | US7223798 treating inflammatory or autoimmune disorders and pulmonary or respiratory tract inflammation |
| 05/29/2007 | US7223777 Such as 1-(2-thien-2'-yl- 2-oxoethyl)-3-((3-phenylmethyl) pyrazol-5-yl)pyridinium bromide for treating diseases caused by the accumulation of AGE (Advanced Glycation Endproducts); antidiabetic/ antiaging agents |
| 05/29/2007 | US7223772 Cyclooxygenase-2 inhibitors (COX-2); 4-[2-(3-fluoro-phenyl)-6-trifluoromethyl-pyrazolo[1,5-a]pyridin-3-yl]benzenesulfonamide for example; fever, pain, inflammation, neurodegenerative disorders, oral diseases, influenza, arthritis, allergies |
| 05/29/2007 | US7223760 Substituted triazole compounds |
| 05/29/2007 | US7223755 Such as (2S,5S)-5-benzyl-6-hydroxy-2-(2-methylpropyl)-3-morpholinone, which has calpain inhibitory activity; for treating cataract or retinal ischemic disorder |
| 05/29/2007 | US7223751 Sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same |
| 05/29/2007 | US7223746 Ocular hypotensive agents; asthma, dysmenorrheal, osteoporosis, constipation, renal/sexual disorders, baldness, diabetes, cancer, immune disorders, acute myocardial infarction, vascular thrombosis, hypertension, pulmonary hypertension, ischemic heart disease, congestive heart failure, and angina |
| 05/29/2007 | US7223394 Human antibodies that bind human TNFα |
| 05/24/2007 | WO2007059021A1 Soft anticholinergic zwitterions |
| 05/24/2007 | WO2007058322A1 Basic group-containing compound and use thereof |
| 05/24/2007 | WO2007024860A3 Sulfonamides |
| 05/24/2007 | WO2007020671A8 Ophthalmic compositions containing mucoadhesive polysaccharides able to promote corneal re-epithelization |
| 05/24/2007 | WO2004060266A3 Eye-drop vaccine containing copolymer poly-ye for therapeutic immunization |
| 05/24/2007 | US20070117843 Quinoline inhibitors of cGMP phosphodiesterase |
| 05/24/2007 | US20070117842 Polymorph of 4-[3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6- quinolinecarboxamide and a process for the preparation of the same |
| 05/24/2007 | US20070117790 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 05/24/2007 | US20070117758 Treating treating angiogenic disease, e.g., cancer, by administering therapeutically effective amount of compounds of the invention, for example, {(3R, 4S, 5S, 6R)-5-Methoxy-4-[(2R, 3R)-2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-1-oxa-spiro[2.5]oct-6-yloxycarbonylamino}-3-methyl-butyric acid methyl ester |
| 05/24/2007 | US20070117754 Nectin polypeptides, polynucleotides, methods of making and use thereof |
| 05/24/2007 | US20070117180 Enzyme producing plasma protein fragment having inhibitory activity to metastasis and growth of cancer and plasma protein fragment produced by fragmentation by said enzyme |
| 05/24/2007 | US20070117091 Anti-candida agents for the treatment of prion diseases |
| 05/24/2007 | US20070116688 Methods of organ regeneration |
| 05/24/2007 | US20070116685 Endothelial progenitor cells that express CD31 and c-kit, and not more than one percent express Tie-2 antigen; cell therapy for eye disorders |
| 05/24/2007 | US20070113727 Wireless microphone communication system |
| 05/24/2007 | DE102005055275A1 Phosphatfreie pharmazeutische Zusammensetzung sowie deren Verwendung Phosphate-free pharmaceutical composition and use thereof |
| 05/24/2007 | CA2627982A1 Soft anticholinergic esters |
| 05/23/2007 | EP1788000A1 Agent for preventing and ameliorating obesity |
| 05/23/2007 | EP1787999A1 Anti-VEGF antibodies |
| 05/23/2007 | EP1787655A2 Meningococcal vaccine composition |
| 05/23/2007 | EP1787643A1 Implants and microspheres for the sustained release of drugs for ophthalmic use and preparation methods thereof |
| 05/23/2007 | EP1786426A1 Soluble amide & ester pyrazinoylguanidine sodium channel blockers |
| 05/23/2007 | EP1585743B1 2-(1h-indazol-6-ylamino)- benzamide compounds as protein kinases inhibitors useful for the treatment of ophthalmic diseases |
| 05/23/2007 | EP1363885B1 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof |
| 05/23/2007 | EP1259282A4 Method and apparatus for transcutaneous infusion of carbon dioxide for local relief of pain and other ailments |
| 05/23/2007 | CN1966725A Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma |
| 05/23/2007 | CN1965877A Chinese medicinal eye drop for treating bacteria and virus infected conjunctivitis |
| 05/23/2007 | CN1965857A Eye drop of povidone iodine and preparation process thereof |
| 05/23/2007 | CN1965854A Moisturizing eye drop and preparation process therof |
| 05/23/2007 | CN1965825A Ocular surface applied medicament for treating eyes immunological disease and inhibiting proliferation and neovascularization |
| 05/23/2007 | CN1317278C Heterocyclic compounds and their use as medicines |
| 05/23/2007 | CN1317020C Oral liquor for curing ophthalmokopia |
| 05/23/2007 | CN1316975C Puerarin prepn for eye and its prepn process |
| 05/23/2007 | CN1316969C Ophthalmic preparation of fluconazole and method for preparing the same |
| 05/22/2007 | US7220867 Dissolving with crystal growth inihibitos; drying |
| 05/22/2007 | US7220856 Substituted quinoline CCR5 receptor antagonists |
| 05/22/2007 | US7220780 Naaladase inhibitors for treating retinal disorders and glaucoma |
| 05/22/2007 | US7220771 Jun n-terminal kinase inhibitors |
| 05/22/2007 | US7220769 Azolylbenzamides and analogues and their use for treating osteoporosis |
| 05/22/2007 | US7220752 Liver selective glucocorticoid receptor antagonists; lowering blood glucose levels; 3,5-dibromo-4-(5-isopropyl-2-(3-methylbenzoyl)-4-(3-methyl-3-b utenyloxy)phenoxy)-phenylacetic acid for example |
| 05/22/2007 | US7220719 Using recombinant zinc finger proteins; use in human therapeutic applications such as cancer therapy and altering plant phenotypes, including disease resistance, fruit ripening |
| 05/22/2007 | US7220422 In situ adminiatering Clostridium toxin; antiinflammatory agents |
| 05/22/2007 | CA2321560C The use of a protein tyrosine inhibitor such as genistein in the treatment of diabetic retinopathy or ocular inflammation |
| 05/22/2007 | CA2241466C Pharmaceutical composition containing angiotensin ii antagonist |
| 05/22/2007 | CA2157579C Heterocyclic compounds, their use and preparation |
| 05/18/2007 | WO2007056087A1 Prostaglandins and analogues as agents for lowering intraocular pressure |
| 05/18/2007 | WO2007055224A1 Therapeutic agent for corneal disease |
| 05/18/2007 | WO2007054822A2 Use of at least one avermectin or milbemycin in the treatment of ophthalmic pathologies |
| 05/18/2007 | WO2007054580A1 N-sulfamoyl-n’-benzopyranpiperidines as inhbitors of carbonic anhydrases |
| 05/18/2007 | WO2007054566A2 Use of fenofibrate or a derivative thereof for preventing diabetic retinopathy |
| 05/18/2007 | WO2007024611A3 Sulfonamides of 7 -aminoheptanoic acid derivatives for treating glaucoma |
| 05/18/2007 | WO2006029487A8 Platelet factor 4 variant 1 (pf4var1) related inhibitors of angiogenesis |
| 05/18/2007 | CA2629864A1 N-sulfamoyl-n'-benzopyranpiperidines as inhbitors of carbonic anhydrases |
| 05/18/2007 | CA2628508A1 Use of fenofibrate or a derivative thereof for preventing diabetic retinopathy |
| 05/18/2007 | CA2628413A1 Prostaglandins and analogues as agents for lowering intraocular pressure |
| 05/18/2007 | CA2620814A1 Use of at least one compound of the family of the avermectins or of the family of the milbemycins in the treatment of ophthalmic pathologies |
| 05/17/2007 | US20070112046 2'-Methyl-5'-(1,3,4-Oxadiazol-2-yl)-1,1'-Biphenyl-4-Carboxamide Derivatives and Their Use As P38 Kinase Inhibitors |
| 05/17/2007 | US20070112029 Piperidine compound and process for preparing the same |
| 05/17/2007 | US20070112025 Use of kynurenine-3-hydroxylase inhibitors for the preparation of medicaments for the treatment of l-dopa induced movement disorders, dyskinesias, drug addiction, pain and cataract |
| 05/17/2007 | US20070110735 administering to the heart of subject in need of increased capillary density in the heart a trk receptor ligand in an amount effective to increase capillary density in the heart, said trk receptor ligand being selected from the group consisting of brain-derived neurotrophic factor, NT-3, and NT-4. |
| 05/16/2007 | EP1785145A1 Transnasal composition having immediate action and high absorbability |
| 05/16/2007 | EP1785134A2 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 05/16/2007 | EP1785133A1 Use of fenofibrate or a derivative thereof for preventing diabetic retinopathy |
| 05/16/2007 | EP1784182A1 2-sulfanyl-benzimidazol-1-yl-acetic acid derivatives as crth2 antagonists |
| 05/16/2007 | EP1784181A1 Vegf inhibition |
| 05/16/2007 | EP1784171A1 Topical otic compositions and methods of topical treatment or prevention of otic infections |
| 05/16/2007 | EP1784164A2 Methods for transmembrane treatment and prevention of otitis media |
| 05/16/2007 | EP1306373B1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
| 05/16/2007 | EP1305285B1 N-substituted indoles useful in the treatment of diabetes |
| 05/16/2007 | EP1265900B1 1,5-disubstituted-3,4-dihydro-1h-pyrimido 4,5-d|pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| 05/16/2007 | CN1964723A Agent for visualizing transparent tissue |
| 05/16/2007 | CN1964719A Use of loteprednol etabonate for the treatment of dry eye |
| 05/16/2007 | CN1964706A Prevention of retinopathy by inhibition of the visual cycle |
| 05/16/2007 | CN1962641A Metalloproteinase inhibitors |
| 05/16/2007 | CN1315847C 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 05/16/2007 | CN1315840C Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives used as drug for treating pain |
| 05/16/2007 | CN1315838C 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 05/16/2007 | CN1315835C Polycyclic guanine phosphodiesterase v inhibitors |
| 05/16/2007 | CN1315833C Azaindole kinase inhibitors |
| 05/16/2007 | CN1315832C Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropydimido[1,2-a]pyrimidin-4-one derivatives |
| 05/16/2007 | CN1315822C Quinoline derivatives having VEGF inhibiting activity |
| 05/16/2007 | CN1315806C Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 05/16/2007 | CN1315531C Remedies for dry eye and diseases associated with dry eye |
| 05/16/2007 | CN1315502C Drug-resistant rapid-acting eyedrops without stimulation |
| 05/16/2007 | CN1315479C Use of oleuropein in preparation of drug for inhibiting angiogenesis |
| 05/16/2007 | CN1315471C Basis-reinforcing eyesight-improving dropping pill for treating eye disease and its preparing method |